Shoulder Implant Market Will Exceed $540 Million by 2012

Wednesday, September 19, 2007 General News J E 4
WALTHAM, Mass., Sept. 18 Millennium Research Group (MRG)has conducted a detailed analysis of the small-joint market in its USMarketsfor Small-Joint Devices 2007 report. The analysis reveals that the shoulderimplant market, valued at almost $260 million in 2007, is expected to morethan double to $540 million by 2012. Despite obstacles in this market, growthwill be largely driven by the reverse shoulder implant, a new technology thatmore surgeons are expected to offer in the coming years.

Although the reverse shoulder implant has been used in Europe for over 10years, awareness is only beginning to build in the United States, specificallyat conferences and events. The device primarily targets osteoarthritispatients who want to improve shoulder mobility and live free from pain.Traditional shoulder implants have a prosthetic ball on the humerus (upperarm) component and socket on the scapula (shoulder blade) component. With areverse shoulder, the socket is on the humerus and the ball is on the scapula.

"While lack of surgical training and awareness presently hinder totalshoulder market growth, these limiters will begin to erode over the next fiveyears as surgeons look to specialize in the less established areas of small-joint reconstruction," says Chris Shutsa, Senior Analyst at MillenniumResearch Group. "Furthermore, as patients become more aware of shoulderreplacement options, demand for the procedure will increase."

The US Markets for Small-Joint Devices 2007 report includes coverage ofindustry competitors including Acumed, Biomet, DePuy, Kinetikos MedicalInc/Integra LifeSciences, Stryker, Synthes, Tornier, Wright MedicalTechnology, and Zimmer.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, (, is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.

All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101

SOURCE Millennium Research Group


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Insurance Warrior Offers Rx to Make Insurers Pay
Vion Pharmaceuticals Receives Notice from Nasdaq